These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11389990)

  • 41. Non-viral-mediated gene therapy approaches for bone repair.
    Winn SR; Chen JC; Gong X; Bartholomew SV; Shreenivas S; Ozaki W
    Orthod Craniofac Res; 2005 Aug; 8(3):183-90. PubMed ID: 16022720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-viral vectors in cancer gene therapy: principles and progress.
    Schatzlein AG
    Anticancer Drugs; 2001 Apr; 12(4):275-304. PubMed ID: 11335785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
    Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
    Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells.
    Lee CH; Ni YH; Chen CC; Chou C; Chang FH
    Biochim Biophys Acta; 2003 Apr; 1611(1-2):55-62. PubMed ID: 12659945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fast therapeutic DNA internalization - A high potential transfection system based on a peptide mimicking cationic lipid.
    Janich C; Pinnapireddy SR; Erdmann F; Groth T; Langner A; Bakowsky U; Wölk C
    Eur J Pharm Biopharm; 2017 Sep; 118():38-47. PubMed ID: 27993732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-viral gene therapy: Gains and challenges of non-invasive administration methods.
    Foldvari M; Chen DW; Nafissi N; Calderon D; Narsineni L; Rafiee A
    J Control Release; 2016 Oct; 240():165-190. PubMed ID: 26686079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting gene therapy for prostate cancer cells by liposomes complexed with anti-prostate-specific membrane antigen monoclonal antibody.
    Ikegami S; Yamakami K; Ono T; Sato M; Suzuki S; Yoshimura I; Asano T; Hayakawa M; Tadakuma T
    Hum Gene Ther; 2006 Oct; 17(10):997-1005. PubMed ID: 17032155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipoplex size is a major determinant of in vitro lipofection efficiency.
    Ross PC; Hui SW
    Gene Ther; 1999 Apr; 6(4):651-9. PubMed ID: 10476225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and characterization of laminin-derived peptide AG73-coated liposomes as a selective gene delivery tool.
    Negishi Y; Omata D; Iijima H; Hamano N; Endo-Takahashi Y; Nomizu M; Aramaki Y
    Biol Pharm Bull; 2010; 33(10):1766-9. PubMed ID: 20930391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-viral nucleic acid delivery methods.
    Slivac I; Guay D; Mangion M; Champeil J; Gaillet B
    Expert Opin Biol Ther; 2017 Jan; 17(1):105-118. PubMed ID: 27740858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioinspired Star-Shaped Poly(l-lysine) Polypeptides: Efficient Polymeric Nanocarriers for the Delivery of DNA to Mesenchymal Stem Cells.
    Walsh DP; Murphy RD; Panarella A; Raftery RM; Cavanagh B; Simpson JC; O'Brien FJ; Heise A; Cryan SA
    Mol Pharm; 2018 May; 15(5):1878-1891. PubMed ID: 29590755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
    Arangoa MA; Düzgüneş N; Tros de Ilarduya C
    Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
    Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
    Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocytosis in gene therapy with non-viral vectors.
    Perez Ruiz de Garibay A
    Wien Med Wochenschr; 2016 May; 166(7-8):227-35. PubMed ID: 27141862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A non-viral suicide gene delivery system traversing the blood brain barrier for non-invasive glioma targeting treatment.
    Gao S; Tian H; Xing Z; Zhang D; Guo Y; Guo Z; Zhu X; Chen X
    J Control Release; 2016 Dec; 243():357-369. PubMed ID: 27794494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymer gene delivery: overcoming the obstacles.
    Aied A; Greiser U; Pandit A; Wang W
    Drug Discov Today; 2013 Nov; 18(21-22):1090-8. PubMed ID: 23831858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-activity relationship in cationic lipid mediated gene transfection.
    Niculescu-Duvaz D; Heyes J; Springer CJ
    Curr Med Chem; 2003 Jul; 10(14):1233-61. PubMed ID: 12678797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of cationic liposomes for delivery of diphtheria toxin A-chain gene to cells infected with bovine leukemia virus.
    Lee JT; Watarai S; Kakidani H; Onuma M; Zhao DD; Yasuda T
    J Vet Med Sci; 1997 Mar; 59(3):169-74. PubMed ID: 9101475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors.
    Lu D; Benjamin R; Kim M; Conry RM; Curiel DT
    Cancer Gene Ther; 1994 Dec; 1(4):245-52. PubMed ID: 7627814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and evaluation of novel lipopeptide as a vehicle for efficient gene delivery and gene silencing.
    Koloskova OO; Nikonova AA; Budanova UA; Shilovskiy IP; Kofiadi IA; Ivanov AV; Smirnova OA; Zverev VV; Sebaykin YL; Andreev SM; Khaitov MR
    Eur J Pharm Biopharm; 2016 May; 102():159-67. PubMed ID: 26992289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.